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We congratulate Blair et al. (2009) and 
Boffetta et al. (2008) for drawing proper 
attention to the rhetoric of false-positive 
results concerning environmental determi-
nants and human health outcomes.
In particular, Boffetta et al. (2008) sug-
gested that “users of epidemiological results 
outside the scientific community . . . should 
be aware of the fact that statistically signifi-
cant or positive results are often false” and 
that “epidemiology is particularly prone to 
the generation of false-positive results.” Blair 
et al. correctly replied that not only could 
false-positive results be generated (2009) 
but also false-negative results. In particu-
lar, in a review of 39 highly cited (citation 
index > 1,000) randomized controlled trials 
that reported an original claim of an effect 
(Ioannidis 2005), only the results of 19 tri-
als were replicated by subsequent studies. 
Therefore, caution should be applied in the 
communication of results to the media and 
the general public, because both tend to 
consider numbers and percentages as the 
“truth” and make their own specu  la  tions on 
data that are often based on inferences and 
weak associations. 
However, the question of non  repro-
ducibility of scientific results cannot be 
reduced to a mere controversy among epi-
demiologists—a controversy that should be 
limited strictly to them and treated only by 
improving statistical methods. It actually 
affects the basis of empirical knowledge, in 
particular when it involves biological and 
medical questions. When sensational new 
discoveries are counter to empirical obser-
vation, caution is mandatory. Biases may 
be detectable by epidemiologists, but there 
are other possible sources of basic errors 
concerning patho  physiologic mechanisms 
that are peculiar to each disease and that 
are unknown to statisticians, who apply the 
same methods to a wide variety of different 
conditions. 
“Biological plausibility” is not enough. 
Individual susceptibility plays a role greater 
than previously supposed in the occurrence 
of clinical outcomes in the host due to 
environ  mental factors. The importance 
of susceptibility reflects a decreased rela-
tive role of pollutant concentration [i.e., 
intrinsic toxicity of xeno  biotics (inhaled or 
ingested)] and reduces the applicability of 
certain models—based on dose and effect 
linearity—to no-threshold phenomena. 
Proper selection of subgroups, which 
should be homogeneous not only for age 
and sex but also for pathophysiological rel-
evance, is not an epidemiologist’s task but 
should be directed also by clinicians and 
pathologists. For example, lung cancer is 
still considered by epidemio  logists as a single 
entity, but clinicians are aware that in addi-
tion to cancer occurring in an anthracotic 
lung, pulmonary cancers may also occur in 
non  anthracotic lungs; this is a different dis-
ease less likely to be dependent on air pollu-
tion. The knowledge of this fact will greatly 
affect population selection.
Finally, Boffetta’s criticism and plea for 
epistemological modesty is not only well 
timed but also necessary. In particular, in 
studies on health effects of environ  mental 
determinants, a common remark is that this 
field should never be the exclusive kingdom 
of environmentalists or epidemiologists; 
clini  cians should play a vigorous role as 
scien  tists with direct experience. Therefore, a 
senior clini  cian having long-term experience 
with the disease of concern should always 
be involved in the design of the study and 
in reporting study results. Interdisciplinary 
control of research is not only a desirable 
option but a necessary measure to mitigate 
the sensational effect of new discoveries. This 
is true in particular when, despite statistical 
significance of observed differences, findings 
are counter to everyday clini  cal experience 
or they are not clearly adherent to—or a 
logical consequence of—strict criteria such 
as Koch’s postulates. Clinicians could also 
suggest the proper timing for large and 
expensive epidemiological trials, which 
should be performed exclusively when ade-
quate metrics and reliable patho  physiologic 
causa  tive mechanisms between determinants 
and outcomes have been established. Our 
view is that clinicians should be involved 
both in the study design and timing, so that 
inter  disciplinary control of the study can be 
guaranteed from the beginning.
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Erratum
The Editor’s Summary for the article “Are Current or Future Mesothelioma Epidemics in 
Hong Kong the Tragic Legacy of Uncontrolled Use of Asbestos in the Past?,” by Tse et al. 
[Environ Health Perspect 118:382–386 (2010); doi:10.1289/ehp.090086], has been cor-
rected online: specifically, “(which has been implicated but not conclusively established as a 
cause of mesothelioma)” has been deleted. The corrected summary appears below.
Inhaled asbestos fibers may contribute to three-fourths of malignant meso  theliomas diagnosed in men and 
almost 40% of cases diagnosed in women. Bans on the manufacture and sale of amphibole asbestos fibers 
are expected to reduce the incidence of mesothelioma, but the long latency period from initial exposure 
to clinical disease means that people exposed before bans were enacted will continue to develop asbestos-
related mesotheliomas as they age. Tse et al. (p. 382) used historical data on asbestos consumption and 
mesothelioma diagnoses to predict future mesothelioma trends in Hong Kong. Asbestos use peaked dur-
ing a construction boom in the early 1960s and subsequently declined by > 90% following a ban on the 
sale and import of crocidolite and amosite asbestos in 1996, whereas mesothelioma diagnoses in men 
increased from a single case in 1972–1976 to 63 cases in 2002–2006 (corresponding to crude incidence 
rates of 0.09 and 3.86 cases/million men, respectively). Assuming an average latency of 42 years, the 
authors predict that incidence rates will peak in 2009 and that diagnoses will peak in 2014. However, 
they caution that ongoing use of chrysotile asbestos and the release of asbestos fibers from older buildings 
during demolition or renovation may slow the projected decline.